Latest Close
$88.01
News
ABVX
Abivax SA News
This news view pulls recent coverage and headlines tied to ABVX.
1y Change
-$2.75 (-3.03%)
Market Cap
$7.68B
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Abivax (ABVX): Cleared Safety Overhang and Phase 3 Data De-Risk Path to Commercialization
Insider Monkey • Oct 7, 2026
Read articleAbivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
GlobeNewswire • Sep 30, 2026
Read articleABIVAX Société Anonyme (ENXTPA:ABVX) Just Gave Investors Something To Think About
Simply Wall St. • Sep 27, 2026
Read articleABIVAX Société Anonyme (ENXTPA:ABVX) Appoints New Chief Medical And Technical Officers
Simply Wall St. • Sep 26, 2026
Read articleABIVAX (ABVX) Uses More Cash. Can its Funding Cover a Potential Launch?
Insider Monkey • Sep 26, 2026
Read articleWedbush Cuts Price Target on Abivax to $118 From $160, Keeps Neutral Rating
MT Newswires • Sep 22, 2026
Read article